COMPUTER SIMULATIONS OF PARTICLE DEPOSITION IN THE LUNGS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS

Epidemiology data show that mortality rates for chronic obstructive pulmonary disease (COPD) patients increase with an increase in concentration of ambient particulate matter (PM). This is not seen for normal subjects. Therefore, the U.S. Environmental Protection Agency (EPA) has identified COPD patients as a susceptible subpopulation to be considered in regulatory standards. In the present study, a computer model was used to calculate deposition fractions of PM within the lungs of COPD patients. The morphology of COPD lungs was characterized by two distinct components: obstruction of airways (chronic bronchitis component), and degeneration of alveolar structure (emphysema component). The chronic bronchitis component was modeled by reducing airway diameters using airway resistance measurements in vivo, and the emphysema component was modeled by increasing alveolar volumes. Calculated results were compared with experimental data obtained from COPD patients for controlled breathing trials (tidal volume of 500 ml, respiratory time of 1 s) with a particle size of 1 µm. The model successfully depicts PM deposition patterns and their dependence on the severity of disease. The findings indicate that airway obstructions are the main cause for increased deposition in the COPD lung.

[1]  T. Martonen,et al.  Deposition Patterns of Aerosolized Drugs Within Human Lungs: Effects of Ventilatory Parameters , 1993, Pharmaceutical Research.

[2]  P G Georgopoulos,et al.  Integrated exposure and dose modeling and analysis system. 3. Deposition of inhaled particles in the human respiratory tract. , 2001, Environmental science & technology.

[3]  A. J. Bailer,et al.  Methodological issues of using observational human data in lung dosimetry models for particulates. , 2001, The Science of the total environment.

[4]  Yung-sung Cheng,et al.  Deposition of Ultrafine Particles in Human Tracheobronchial Airways of Adults and Children , 2001 .

[5]  R. Segal,et al.  Comparison of Computer Simulations of Total Lung Deposition to Human Subject Data in Healthy Test Subjects , 2000, Journal of the Air & Waste Management Association.

[6]  S. Rennard COPD: overview of definitions, epidemiology, and factors influencing its development. , 1998, Chest.

[7]  W. Bailey,et al.  Strategies in preserving lung health and preventing COPD and associated diseases. The National Lung Health Education Program (NLHEP). , 1998, Chest.

[8]  C. Kim,et al.  Comparative measurement of lung deposition of inhaled fine particles in normal subjects and patients with obstructive airway disease. , 1997, American journal of respiratory and critical care medicine.

[9]  S. Walters,et al.  Short term variations in hospital admissions and mortality and particulate air pollution. , 1997, Occupational and environmental medicine.

[10]  W. Bennett,et al.  ENHANCED DEPOSITION OF FINE PARTICLES IN COPD PATIENTS SPONTANEOUSLY BREATHING AT REST , 1997 .

[11]  J Schwartz,et al.  Air Pollution and Hospital Admissions for Respiratory Disease , 1996, Epidemiology.

[12]  W. MacNee,et al.  Particulate air pollution and acute health effects , 1995, The Lancet.

[13]  T. Martonen,et al.  Interspecies Modeling of Inhaled Gases , 1995 .

[14]  T. Martonen,et al.  Inter-related effects of morphology and ventilation on drug deposition patterns , 1994 .

[15]  T. Martonen Mathematical model for the selective deposition of inhaled pharmaceuticals. , 1993, Journal of pharmaceutical sciences.

[16]  I. Katz,et al.  Deposition Patterns of Polydisperse Aerosols Within Human Lungs , 1993 .

[17]  M. Svartengren,et al.  Regional Deposition of 3.6μm Particles in Subjects with Mild to Moderately Severe Asthma , 1990 .

[18]  J. Heyder,et al.  Effect of cystic fibrosis on inhaled aerosol boluses. , 1989, The American review of respiratory disease.

[19]  Chong S. Kim Aerosol Deposition in the Lung with Obstructed Airways , 1989 .

[20]  M. Sackner,et al.  Enhanced aerosol deposition in the lung with mild airways obstruction. , 1989, The American review of respiratory disease.

[21]  M. Sackner,et al.  Measurement of total lung aerosol deposition as an index of lung abnormality. , 1988, Journal of applied physiology.

[22]  H. Wagner,et al.  The effect of bronchial obstruction on central airway deposition of a saline aerosol in patients with asthma. , 1986, The American review of respiratory disease.

[23]  C. Kim,et al.  Aerosol deposition in the airway model with excessive mucus secretions. , 1985, Journal of applied physiology.

[24]  M. Sackner,et al.  Deposition of aerosol particles and flow resistance in mathematical and experimental airway models. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[25]  T. Martonen Analytical model of hygroscopic particle behavior in human airways. , 1982, Bulletin of mathematical biology.

[26]  J. Mead,et al.  Effect of lung inflation on bronchial length and diameter in excised lungs. , 1972, Journal of applied physiology.

[27]  R C Schroter,et al.  The prediction of pressure drop and variation of resistance within the human bronchial airways. , 1970, Respiration physiology.

[28]  C. Carrington,et al.  Morphometry of the Human Lung , 1965, The Yale Journal of Biology and Medicine.

[29]  R. Hyatt,et al.  Extrathoracic airway resistance in man. , 1961, Journal of applied physiology.